KV

Kirti Vishwamitra

Active Director Director DIN 11003952
DIN 11003952 First appointment Mar 2025 Primary industry Oil & Gas
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Kirti Vishwamitra

Data last updated:

Kirti Vishwamitra is a Director at Anvinex Pharma Private Limited (since 2025). The company operates in Oil & Gas.

DIN 11003952
Primary Designation Director
Industry Oil & Gas
First Appointment 17 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Anvinex Pharma Private Limited U23104UP2025PTC219164
Director17 Mar 20252025Active

Board colleagues of Kirti Vishwamitra

Directorship timeline

Open interactive timeline →
Anvinex Pharma Private Limited
Premium access

Shareholding and investment profile for Kirti Vishwamitra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kirti Vishwamitra

Kirti Vishwamitra currently holds 1 directorship: Anvinex Pharma Private Limited (Director, since 17 Mar 2025).

Kirti Vishwamitra was first appointed on 17 Mar 2025 as Director at Anvinex Pharma Private Limited.

The current boards of Kirti Vishwamitra's companies include Pooja Chahar (Anvinex Pharma Private Limited), Poonam Singh (Anvinex Pharma Private Limited), Preeti Jain (Anvinex Pharma Private Limited), Priyanka Singh (Anvinex Pharma Private Limited), Rekha Devi (Anvinex Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available